N-Acetylcysteine Alpex 200 mg
N-Acetylcysteine Alpex 200 mg is a medicine authorised by Swissmedic under authorisation number 61348. The authorisation holder is Alpex Pharma SA. The medicinal product code is Synthetic medicines and the dispensing category is B/D: The medicine has strengths in category B and in category D, so supply depends on the strength. First authorisation was granted on 01 June 2011 and the authorisation is valid without a time limit. ATC code R05CB01 places the medicine in the group Cough and cold preparations.
| Authorisation number | 61348 |
|---|---|
| Name | N-Acetylcysteine Alpex 200 mg |
| Full name | N-Acetylcysteine Alpex 200 mg, compresse effervescenti |
| Authorisation holder | Alpex Pharma SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B/D · Mixed B and D |
| ATC code | R05CB01 |
| First authorisation | 01 June 2011 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | N-Acetylcysteine Alpex 200 mg, compresse effervescenti | D | 01 June 2011 |
| 2 | N-Acetylcysteine Alpex 600 mg, compresse effervescenti | B/D | 01 June 2011 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 10 | Tablette(n) | R05CB01 | 03.02.0. | D |
| 2 | 20 (2 x 10) | Tablette(n) | R05CB01 | 03.02.0. | D |
| 3 | 6 | Tablette(n) | R05CB01 | 03.02.0. | D |
| 4 | 12 (2 x 6) | Tablette(n) | R05CB01 | 03.02.0. | D |
| 5 | 10 | Tablette(n) | R05CB01 | 03.02.0. | D |
| 6 | 20 (2 x 10) | Tablette(n) | R05CB01 | 03.02.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Frequently asked questions
Is N-Acetylcysteine Alpex 200 mg authorised in Switzerland?
Yes. N-Acetylcysteine Alpex 200 mg is authorised by Swissmedic under authorisation number 61348, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does N-Acetylcysteine Alpex 200 mg have?
N-Acetylcysteine Alpex 200 mg is in dispensing category B/D. The medicine has strengths in category B and in category D, so supply depends on the strength.
Who is the authorisation holder of N-Acetylcysteine Alpex 200 mg?
The authorisation holder is Alpex Pharma SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.